FDA approves Boostrix to prevent three diseases in older people

Share this article:
FDA approves Boostrix to prevent three diseases in older people
FDA approves Boostrix to prevent three diseases in older people

The Food and Drug Administration has approved the Boostrix vaccine for the treatment of  tetanus, diphtheria and pertussis (whooping cough) in people ages 65 and older. Boostrix is the first vaccine approved to prevent all three diseases in older people.

“Pertussis is a highly contagious disease and outbreaks have occurred among the elderly in nursing homes and hospitals,” said Karen Midthun, M.D., director of FDA's Center for Biologics Evaluation and Research


Share this article:

More in Products

LeadingAge's CAST releases medication management tools

LeadingAge's Center for Aging Services Technologies release new tools last week to help long-term care providers identify the best medication management product.

Butler Mobility updates paint colors for platform lifts

Butler Mobility updates paint colors for platform lifts

Butler Mobility has widened the spectrum of paint color choices for its Incline Platform Lifts line.

NeuroMetrix releases pain management system

NeuroMetrix releases pain management system

NeuroMetrix Inc. has created the SENSUS™ Pain Management System, a wearable neurostimulation technology developed for chronic neuropathic pain, including painful diabetic neuropathy.